Month: August 2025

CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) — GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, today reported its results for the second quarter 2025. GCM Grosvenor issued a detailed presentation of its results to the Public Shareholders section of GCM Grosvenor’s website at https://www.gcmgrosvenor.com/shareholder-events. GCM Grosvenor’s Board of Director’s increased the firm’s existing share repurchase authorization by $30 million, from $190 million to $220 million. The firm’s Board of Directors also approved a $0.11 per share dividend payable on September 16, 2025 to shareholders on record September 2, 2025. Conference Call A conference call to discuss GCM Grosvenor’s financial results will be held today, Thursday, August 7, 2025, at 11:00 a.m. ET. The call will be accessible via public...

OMAHA, Neb., Aug. 07, 2025 (GLOBE NEWSWIRE) — On August 7, 2025, Greystone Housing Impact Investors LP (NYSE: GHI) (the “Partnership”) announced financial results for the three months ended June 30, 2025. The Partnership will host a call today at 4:30 p.m. Eastern Time to discuss the results and business outlook. Details for accessing the call can be found below under “Earnings Webcast & Conference Call.” Financial Highlights The Partnership reported the following results as of and for the three months ended June 30, 2025:Net loss of $7.1 million or $0.35 per Beneficial Unit Certificate (“BUC”), basic and diluted Cash Available for Distribution (“CAD”) of $5.7 million or $0.25 per BUC Total assets of $1.48 billion Total Mortgage Revenue Bond (“MRB”) and Governmental Issuer Loan (“GIL”) investments of $1.13 billionThe...

SOUTH SAN FRANCISCO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today reported financial results for the second quarter of 2025 and provided a summary of recent pipeline and corporate highlights. “Our team has continued to advance SENTI-202’s clinical development. We have now completed dose finding and have confirmed the recommended Phase 2 dose (RP2D), which is an important step in our Phase 1 study. We are currently in the dose expansion phase, enrolling additional patients with relapsed/refractory AML at the RP2D. Additionally, we recently received Orphan Drug Designation for SENTI-202 and bolstered the leadership and expertise of our team,...

BALTIMORE, Aug. 07, 2025 (GLOBE NEWSWIRE) — MarketWise, Inc. (NASDAQ: MKTW) (“MarketWise” or the “Company”), a leading multi-brand digital subscription services platform that provides premium financial research, software, education, and tools for self-directed investors, today reported financial results for second quarter 2025.(1) Second Quarter 2025 Highlights(1)(2)Total net revenue was $80.0 million in the second quarter 2025(2)Total Billings were $58.2 million in second quarter 2025, a year-over-year increase of 10% on an adjusted basis Net income was $15.3 million in second quarter 2025 Cash from Operating Activities was $17.8 million in second quarter 2025, an improvement of $21.6 million compared to second quarter 2024 Cash and cash equivalents were $69.1 million as of June 30, 2025, and no debt outstanding Announced...

Second Quarter Highlights – 2025 vs. 2024Verification and certification revenue: $5.33M vs. $5.25M Product sales: $964,000 vs. $819,000 Total revenue: $6.6M vs. $6.4M Net income: $562,000 vs. $489,000 Diluted EPS: $0.11 vs. $0.09 Stock buybacks: 24,481 sharesSix Month Highlights – 2025 vs. 2024Verification and certification revenue: $9.5M vs. $9.7M Product sales: $1.7M vs. $1.6M Total revenue: $11.8M vs. $12.0M Net income: $593,000 vs. $667,000 Diluted EPS: $0.11 vs. $0.12 Cash generated from operations: $1.8M vs. $1.9M Cash & cash equivalents: $3.2M vs. $2.0M at 2024 year-end Stock buybacks: 55,826 shares Total buybacks since plan inception plus private purchases: 1,247,462 shares at purchase price of approximately $13.6 million $14.6M in total value returned to stockholders via buybacks, private purchases and a special dividend...

ATLANTA, Aug. 07, 2025 (GLOBE NEWSWIRE) — Cumulus Media Inc. (OTCQB: CMLS) (the “Company,” “Cumulus Media,” “we,” “us,” or “our”) today announced operating results for the three and six months ended June 30, 2025. Mary G. Berner, President and Chief Executive Officer of Cumulus Media, said, “While the advertising backdrop for legacy media remains challenging, in the quarter we continued to outperform our radio peers, gaining market share across all broadcast spot revenue channels. We also significantly outperformed in digital, delivering double the growth rate of our radio peers, driven by the 38% year-over-year increase in our digital marketing services business. Additionally, we executed $5 million of annualized cost reductions, bringing total annualized cost reductions...

— Announced positive data from two patients in Phase 1/2 clinical trial in Chronic Granulomatous Disease (CGD), providing clinical proof-of-concept for Prime Editing; plan to have regulatory interactions based on current dataset — — Completed follow-on offering, raising $144.2 million in gross proceeds and extending cash runway into 2027 — — Secured up to $24 million in additional funding from the Cystic Fibrosis Foundation to advance Prime Editors for Cystic Fibrosis — — Announced leadership transition and strategic restructuring: Allan Reine, M.D., named Chief Executive Officer; focusing efforts on advancing liver franchise and programs funded through external partnerships — CAMBRIDGE, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) — Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company...

WILMINGTON, Del., Aug. 07, 2025 (GLOBE NEWSWIRE) — Acorn Energy, Inc. (Nasdaq: ACFN), a provider of remote monitoring and control solutions for backup generators, gas pipelines and other critical infrastructure assets, announced results for its second quarter ended June 30, 2025 (Q2’25). Acorn will hold an investor call today at 11 a.m. ET (details below).Summary Financial Results($ in thousands) Q2’25 Q2’24 Change   6M’25 6M’24 ChangeMonitoring revenue $ 1,320     $ 1,110     +18.9%     $ 2,589     $ 2,212     +17.0%  Hardware revenue $ 2,205     $ 1,165     +89.3%     $ 4,034     $ 2,195     +83.8%  Total revenue(1) $ 3,525     $ 2,275     +54.9%     $ 6,623     $ 4,407     +50.3%  Gross margin   74.9%       73.2%     +170bps       75.0%       73.9%     +110bps  Net income to stockholders(2) $ 720     $ 271     +165.7%     $ 1,184     $ 336     +252.4%  Net...